Pediatria Polska

Abstract

1/2025 vol. 100
Case report

Pleuropulmonary blastoma – primary malignant lung tumor in children

  1. Department of Pediatric Hematology and Oncology, Collegium Medicum, Nicolaus Copernicus University in Toruń, Bydgoszcz, Poland
Pediatr Pol 2025; 100 (1): 102-104
Online publish date: 2025/03/28
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
Pleuropulmonary blastoma (PPB) is a primary, malignant tumor in children up to 6 years of age. It is a rare tumor and may cause diagnostic difficulties. A 3-year-old girl was hospitalized due to pneumonia and dyspnea. Based on the symptoms, laboratory tests and computed tomography images, inflammatory changes were suspected to be caused by a congenital lung defect. There was no improvement after conservative treatment, so the decayed basal segments of the left lower lobe were removed by thoracotomy. Histopathological examination confirmed PPB type III with the DICER1 mutation. The girl underwent postoperative chemotherapy. There were no signs of progression after treatment. Pleuropulmonary blastoma is a malignant tumor and requires combined oncological treatment. The prognosis depends on the histological type and radical tumor resection. Testing for the DICER1 mutation is helpful in the diagnosis of solid-cystic lung lesions in children.
Share
without publication fees
without publication fees